1. Alexion says “no” to investor proactive sale demand — FDA approves first copycats of Novartis MS drug Gilenya — $178M stockpile of Merck ebola vaccine authorized — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

End of the road?

Discussion in 'Promius Pharma' started by Garsanth, Sep 7, 2018 at 11:24 PM.

Tags: Add Tags
  1. Garsanth

    Garsanth Guest

    Will this last another year?

    Does Derm even have a pipeline? Or BD activities?

    Does anyone care about another niche migraine product? Wonder if Neuro will grow?

    And what happened to Compliance?

    And a dedicated HR person?

    And why don't they tell us when people leave or are laid off?

    How much does DRL think they can get for us?

    Who'd be dumb enough to buy us?

    Does anyone Senior Director or higher give a sh*t?

    Does anyone Senior Director or higher not have sh*t for brains?

    Is it me or are we really sinking fast?
     

  2. anonymous

    anonymous Guest

    just keep sampling and making your calls and it will all be ok sweet child

    - from india with love
     
  3. anonymous

    anonymous Guest

    The company is excepting bids, but they will tell you everything is fine! HR is a joke! Management is a joke! Look for jobs... most good reps have left since January.
     
  4. anonymous

    anonymous Guest

    "excepting" Good God man!!!!